Fate Historical Income Statement
| FATE Stock | USD 3.95 0.09 2.23% |
Historical analysis of Fate Therapeutics income statement accounts such as Selling General Administrative of 85.5 M or Total Revenue of 66.7 M can show how well Fate Therapeutics performed in making a profits. Evaluating Fate Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fate Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Fate Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fate Therapeutics is a good buy for the upcoming year.
Fate |
About Fate Income Statement Analysis
Fate Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fate Therapeutics shareholders. The income statement also shows Fate investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Fate Therapeutics Income Statement Chart
Fate Therapeutics Income Statement is one of the three primary financial statements used for reporting Fate's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fate Therapeutics revenue and expense. Fate Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Fate Therapeutics' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 85.5 M, whereas Operating Income is projected to grow to (168.7 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Fate Therapeutics. It is also known as Fate Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Fate Therapeutics income statement and represents the costs associated with goods and services Fate Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Fate Therapeutics financial statement analysis. It represents the amount of money remaining after all of Fate Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Fate Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fate Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fate Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.At present, Fate Therapeutics' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 85.5 M, whereas Operating Income is projected to grow to (168.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 4.5M | 5.8M | 6.7M | 7.1M | Depreciation And Amortization | 1.3M | 13.8M | 18.3M | 19.2M |
Fate Therapeutics income statement Correlations
Click cells to compare fundamentals
Fate Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fate Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 4.3M | 2.4M | 1.3M | 13.8M | 18.3M | 19.2M | |
| Interest Expense | 1.8M | 2.4M | 4.5M | 5.8M | 6.7M | 7.1M | |
| Selling General Administrative | 23.6M | 33.9M | 57.3M | 84.2M | 81.4M | 85.5M | |
| Total Revenue | 10.7M | 31.4M | 55.8M | 96.3M | 63.5M | 66.7M | |
| Gross Profit | (77.1M) | (94.2M) | 50.0M | 96.3M | 45.3M | 47.5M | |
| Other Operating Expenses | 111.4M | 159.5M | 272.8M | 404.7M | 241.1M | 122.6M | |
| Operating Income | (100.7M) | (128.1M) | (217.0M) | (308.4M) | (177.6M) | (168.7M) | |
| Ebit | (100.7M) | (128.1M) | (217.0M) | (308.4M) | (177.6M) | (168.7M) | |
| Research Development | 87.8M | 125.6M | 215.5M | 320.5M | 143.4M | 91.4M | |
| Ebitda | (96.4M) | (125.7M) | (215.7M) | (294.6M) | (159.3M) | (151.4M) | |
| Cost Of Revenue | 87.8M | 125.6M | 5.9M | 13.8M | 18.3M | 17.4M | |
| Total Operating Expenses | 111.4M | 159.5M | 272.8M | 404.7M | 222.9M | 121.0M | |
| Income Before Tax | (98.1M) | (173.4M) | (212.2M) | (281.7M) | (160.9M) | (152.9M) | |
| Total Other Income Expense Net | 2.6M | (45.3M) | 4.8M | 26.7M | 16.7M | 17.5M | |
| Net Income | (97.7M) | (170.3M) | (206.3M) | (255.1M) | (160.9M) | (152.9M) | |
| Income Tax Expense | (441K) | (3.1M) | (5.9M) | (26.7M) | (24.0M) | (22.8M) | |
| Net Income From Continuing Ops | (98.1M) | (173.4M) | (212.2M) | (281.7M) | (173.2M) | (164.5M) | |
| Non Operating Income Net Other | 494K | 2.6M | (45.3M) | 4.8M | 4.4M | 4.6M | |
| Net Income Applicable To Common Shares | (98.1M) | (173.4M) | (212.2M) | (281.7M) | (253.5M) | (240.9M) | |
| Interest Income | 4.3M | 2.4M | 1.3M | 5.8M | 15.7M | 16.4M | |
| Net Interest Income | 2.6M | 2.4M | 1.3M | 5.8M | 15.7M | 16.4M | |
| Reconciled Depreciation | 2.2M | 3.1M | 5.9M | 13.8M | 18.2M | 19.2M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fate Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Fate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share 0.646 | Quarterly Revenue Growth (0.96) | Return On Assets (0.18) | Return On Equity (0.38) |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.